Click to rate this post!
[Total: 0 Your Rating: 0]You must sign in to vote
DeoBioSciences (DBS) is a stealth mode, R&D stage, virtual biotech developing a cancer drug, based on a naturally occurring compound, that selectively kills both early and advanced stage cancer cells from humans and, potentially, dogs and cats as well.
Major biotechs and pharmas have confirmed, in writing, their interest in pursuing in-licensing or partnerships, upon the presentation of more positive data
Cornell University’s top scientists, among others, are anxious to continue working with us to take our research to the next level
Their stealth tech has other potential applications that we will pursue to maximize our chances of success